» Articles » PMID: 20675660

Impact of Early Vs. Late Microvascular Obstruction Assessed by Magnetic Resonance Imaging on Long-term Outcome After ST-elevation Myocardial Infarction: a Comparison with Traditional Prognostic Markers

Overview
Journal Eur Heart J
Date 2010 Aug 3
PMID 20675660
Citations 73
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Early and late microvascular obstruction (MO) assessed by magnetic resonance imaging (MRI) are prognostic markers for combined clinical endpoints after ST-elevation myocardial infarction (STEMI). However, there are only limited data for hard endpoints and no consensus exists which of the two best predicts clinical outcome. Furthermore, it is unclear whether the assessment of MO by MRI adds incremental prognostic information independent of traditional outcome markers.

Methods And Results: STEMI patients reperfused by primary angioplasty (n = 438) < 12 h after symptom onset underwent MRI at a median of 3 days after the index event. Microvascular obstruction was measured 1 and 15 min after gadolinium injection (early and late MO). Clinical follow-up was conducted after a median of 19 months. The primary endpoint was defined as a composite of death, non-fatal myocardial re-infarction, and congestive heart failure. In contrast to the presence and extent of early MO, the presence and extent of late MO were independently associated with the composite primary endpoint in the multivariable Cox regression analysis adjusting for post-percutaneous coronary intervention TIMI-flow, ST-resolution, TIMI-risk score, ejection fraction, and infarct size. The presence of late MO was identified as the strongest independent predictor for the occurrence of the composite endpoint (hazard ratio 4.23, 95%CI 1.73-10.34, P = 0.002). Furthermore, the presence and extent of late MO provided an incremental prognostic value above the traditional prognostic markers.

Conclusion: In contrast to early MO, the presence and extent of late MO are strong independent prognosticators after STEMI. www.ClinicalTrials.gov: NCT00299377.

Citing Articles

Incorporating Inflammation Biomarker-Driven Multivariate Predictive Model for Coronary Microcirculatory Dysfunction in Acute Myocardial Infarction Following Emergency Percutaneous Coronary Intervention.

Yao Z, Ding B, Wang J, Qian S, Song X, Li Y Clin Cardiol. 2024; 47(10):e70032.

PMID: 39429096 PMC: 11491760. DOI: 10.1002/clc.70032.


Long-Term Prognostic Value of Infarct Transmurality Determined by Contrast-Enhanced Cardiac Magnetic Resonance after ST-Segment Elevation Myocardial Infarction.

Choi I, Kim H, Gim D, Ki Y, Kim H, Kim S Chonnam Med J. 2024; 60(2):120-128.

PMID: 38841612 PMC: 11148306. DOI: 10.4068/cmj.2024.60.2.120.


Coronary Microcirculation: The Next Frontier in the Management of STEMI.

Milasinovic D, Nedeljkovic O, Maksimovic R, Sobic-Saranovic D, Dukic D, Zobenica V J Clin Med. 2023; 12(4).

PMID: 36836137 PMC: 9962942. DOI: 10.3390/jcm12041602.


Predictive value of myocardial strain on myocardial infarction size by cardiac magnetic resonance imaging in ST-segment elevation myocardial infarction with preserved left ventricular ejection fraction.

Wang Q, Wang J, Ma Y, Wang P, Li Y, Tian J Front Pharmacol. 2022; 13:1015390.

PMID: 36313364 PMC: 9613930. DOI: 10.3389/fphar.2022.1015390.


Sono-assisted-thrombolysis by three-dimensional diagnostic ultrasound improves epicardial recanalization and microvascular perfusion in acute myocardial infarction.

Qiu S, Zhong S, Feng Q, Wang Y, Li D, Zhan J Quant Imaging Med Surg. 2022; 12(10):4852-4864.

PMID: 36185055 PMC: 9511427. DOI: 10.21037/qims-21-1247.